Want to join the conversation?
$OREX 2Q15 Call: Estimates that third-party costs that OREX will bear for US & EU post-marketing obligations will be approx. $20-25MM in remainder of 2015 & approx. $35-45MM for each of 2016 & 2017. Through 2017, OREX is eligible to receive $45MM in anniversary milestones that are not included in current guidance & that helps offset cash expense.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?